Gentian Diagnostics ASA

OB:GENT Stock Report

Market Cap: NOK 629.2m

Gentian Diagnostics Future Growth

Future criteria checks 5/6

Gentian Diagnostics is forecast to grow earnings and revenue by 63.5% and 25.7% per annum respectively while EPS is expected to grow by 103.3% per annum.

Key information

63.5%

Earnings growth rate

103.3%

EPS growth rate

Medical Equipment earnings growth18.9%
Revenue growth rate25.7%
Future return on equityn/a
Analyst coverage

Low

Last updated14 Nov 2024

Recent future growth updates

Analyst Estimates: Here's What Brokers Think Of Gentian Diagnostics ASA (OB:GENT) After Its Annual Report

Feb 14
Analyst Estimates: Here's What Brokers Think Of Gentian Diagnostics ASA (OB:GENT) After Its Annual Report

Recent updates

Investors Appear Satisfied With Gentian Diagnostics ASA's (OB:GENT) Prospects As Shares Rocket 33%

Jun 29
Investors Appear Satisfied With Gentian Diagnostics ASA's (OB:GENT) Prospects As Shares Rocket 33%

Analyst Estimates: Here's What Brokers Think Of Gentian Diagnostics ASA (OB:GENT) After Its Annual Report

Feb 14
Analyst Estimates: Here's What Brokers Think Of Gentian Diagnostics ASA (OB:GENT) After Its Annual Report

Here's Why We're Not At All Concerned With Gentian Diagnostics' (OB:GENT) Cash Burn Situation

Oct 28
Here's Why We're Not At All Concerned With Gentian Diagnostics' (OB:GENT) Cash Burn Situation

We're Not Worried About Gentian Diagnostics' (OB:GENT) Cash Burn

May 11
We're Not Worried About Gentian Diagnostics' (OB:GENT) Cash Burn

Can You Imagine How Gentian Diagnostics' (OB:GENT) Shareholders Feel About The 57% Share Price Increase?

Mar 20
Can You Imagine How Gentian Diagnostics' (OB:GENT) Shareholders Feel About The 57% Share Price Increase?

What Percentage Of Gentian Diagnostics AS (OB:GENT) Shares Do Insiders Own?

Feb 21
What Percentage Of Gentian Diagnostics AS (OB:GENT) Shares Do Insiders Own?

Have Insiders Been Selling Gentian Diagnostics AS (OB:GENT) Shares?

Jan 17
Have Insiders Been Selling Gentian Diagnostics AS (OB:GENT) Shares?

Gentian Diagnostics AS (OB:GENT): When Will It Breakeven?

Dec 14
Gentian Diagnostics AS (OB:GENT): When Will It Breakeven?

Earnings and Revenue Growth Forecasts

OB:GENT - Analysts future estimates and past financials data (NOK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202626132N/AN/A1
12/31/20252012321311
12/31/2024151168181
9/30/202415422231N/A
6/30/2024153-2513N/A
3/31/2024149-61521N/A
12/31/2023142-111115N/A
9/30/2023129-5-12-7N/A
6/30/2023122-14-60N/A
3/31/2023120-18-19-6N/A
12/31/2022112-24-29-14N/A
9/30/2022106-29-34-19N/A
6/30/2022100-26-43-26N/A
3/31/202299-26-42-29N/A
12/31/2021100-25-40-27N/A
9/30/202199-19-24-9N/A
6/30/202196-19-27-16N/A
3/31/202184-17-20-12N/A
12/31/202079-17-19-13N/A
9/30/202072-21-16-13N/A
6/30/202070-19-16-13N/A
3/31/202062-38-28-25N/A
12/31/201955-40-26-21N/A
9/30/201944-46-25-20N/A
6/30/201948-41-22-17N/A
3/31/201947-23-18-12N/A
12/31/201846-20-17-11N/A
9/30/201851-12-23-18N/A
6/30/201841-16N/A-19N/A
3/31/201840-14N/A-16N/A
12/31/201735-15N/A-19N/A
9/30/201734-13N/A-19N/A
6/30/201732-12N/A-18N/A
3/31/201730-13N/A-16N/A
12/31/201631-9N/A-8N/A
12/31/201526-3N/A-5N/A
12/31/201425-3N/A-2N/A
12/31/2013231N/A2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GENT's forecast earnings growth (63.5% per year) is above the savings rate (2.4%).

Earnings vs Market: GENT's earnings (63.5% per year) are forecast to grow faster than the Norwegian market (9.3% per year).

High Growth Earnings: GENT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GENT's revenue (25.7% per year) is forecast to grow faster than the Norwegian market (2.1% per year).

High Growth Revenue: GENT's revenue (25.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if GENT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y